A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Clinical trial NCT02273973 · COMPLETED
Trial details
- NCT number
- NCT02273973
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-12
- Primary completion
- 2017-03-13
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.